US Pharmaceutical Industry Report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Jan 2015

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Cancer Drug News 26 JANUARY 2015

Cancer Drug News 26 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 20 pages

Industry Trend Analysis - CAR-T Market Gaining Traction Industry Brief - EC Favours Iclusig's Approved Indications Throughout Europe Industry Brief - Hybrigenics Launches Inecalcitol Phase II Study In CML Industry Brief - Curis/Aurigene Collaborate To Develop Immuno-Oncology/Precision Oncology Targets ...

Industries: Drug and Medication | Countries: China, World, United States, Europe

Antidepressant Market in the US 2015-2019

Antidepressant Market in the US 2015-2019

  • $ 3 000
  • Industry report
  • by Infiniti Research Limited
  • January 2015
  • 104 pages

About Depression According to the WHO, depression is a common mental disorder which contributes significantly to the global burden of disease. It affects people across communities in the world. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed ...

Industries: Drug and Medication | Countries: United States

Anti-Infective Drug News 26 JANUARY 2015

Anti-Infective Drug News 26 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 16 pages

Industry Trend Analysis - US HCV Drug Pricing Battle To Extend To Europe Industry Brief - Roche/Meiji/Fedora Enter Collaboration For Development Of OP0595 Industry Brief - Valneva To Acquire Dukoral Vaccine From Crucell Industry Brief - Aradigm Granted Key Composition Of Matter Patents For Pulmaquin ...

Industries: Drug and Medication | Countries: United States, Canada, India, World, United Kingdom, Europe, North America

Respiratory Therapy News JANUARY 2015

Respiratory Therapy News JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 8 pages

Industry Trend Analysis - EU Approval For Ofev In IPF Will Create A Blockbuster In An Intense Market Industry Trend Analysis - Pfizer Heads Straight For Most Competitive Indication In Immuno-Oncology Market Industry Brief - Zevtera Gains Swissmedic Approval For Pneumonia Industry Brief - Cempra Announces ...

Industries: Therapy | Countries: United States

World Generic Markets 19 JANUARY 2015

World Generic Markets 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 20 pages

Industry Trend Analysis - Despite Overall Upward Trend, FTC Report Shows Fluctuations In Settlement Agreements Industry Brief - Abbott Completes Acquisition Of CFR Industry Brief - Mylan Launches Valsartan In US Industry Trend Analysis - US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not ...

Industries: Drug and Medication | Countries: United States

Portola Pharmaceuticals Inc

Portola Pharmaceuticals Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 51 pages

A textual analysis of the financial results for Portola Pharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical | Countries: United States

CNS Drug News 19 JANUARY 2015

CNS Drug News 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 24 pages

Industry Trend Analysis - Expanded Portfolio Will Help Biogen Idec Sustain Growth Industry Brief - Neuropore/UCB Enter Worldwide Collaboration And Agreement Industry Brief - FDA Approves AbbVie's Duopa For Motor Fluctuations In Advanced PD Patients Industry Brief - FDA Approves Rytary For PD Industry ...

Industries: Drug and Medication | Countries: Japan, United States

Medical Industry Week 19 JANUARY 2015

Medical Industry Week 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 24 pages

Industry Trend Analysis - Covidien To Accelerate Medtronic's Strategic Triad Industry Brief - Deltex To Sell Fore-Sight Oximeters In UK/Ireland Industry Brief - Braun Becomes Exclusive Distributor For RecoveryRx Pain Device In UK Industry Brief - Muse System Distribution Deal Extended In China Industry ...

Industries: Pathology | Countries: United States, China

A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

  • $ 5 000
  • Industry report
  • by Frost & Sullivan
  • January 2015
  • 122 pages

Key Findings •2014 has turned out to be a flagship year in the history of antibacterial drugs development. oThree new systemic antibacterial drugs gained Food and Drugs Administration (FDA) approval for acute bacterial skin and skin structure infection in 2014, including Dalvance (Durata Therapeutics), ...

Industries: Drug and Medication | Countries: United States, United Kingdom

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.